Key Points
Question
Are transfers of value (TOV) reported by makers of branded prostaglandin analog (PGA) eye drops associated with a greater likelihood of prescribing branded PGAs?
Findings
In this cohort study, recipients of TOV were more likely to prescribe branded PGAs compared to prescribers with no reported TOV, even with a relatively low TOV median. A dose-response association was observed, which was robust even when excluding prescribers with the greatest TOV.
Meaning
The findings in this study show that even small TOV from pharmaceutical companies were associated with greater prescription of branded drugs.